Back
Amgen 10K Form
Sell
50
AMGN
Amgen
Last Price:
245.38
Seasonality Move:
9.68%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-04-28 | 10Q | AMGN/Amgen Quarterly |
2021-02-09 | 10K | AMGN/Amgen Annual |
2020-10-29 | 10Q | AMGN/Amgen Quarterly |
2020-07-29 | 10Q | AMGN/Amgen Quarterly |
2020-05-01 | 10Q | AMGN/Amgen Quarterly |
2020-02-13 | 10K | AMGN/Amgen Annual |
Receive AMGN News And Ratings
See the #1 stock for the next 7 days that we like better than AMGN
AMGN Financial Statistics
Sales & Book Value
Annual Sales: | $25.98B |
---|---|
Cash Flow: | $1.97B |
Price / Cash Flow: | 16.48 |
Annual Sales: | $1.71 |
Price / Book: | 143.1 |
Profitability
EPS (TTM): | 10.16000 |
---|---|
Net Income (TTM): | $5.72B |
Gross Margin: | $19.53B |
Return on Equity: | 85.64% |
Return on Assets: | 9.3% |
Amgen Earnings Forecast
Key Amgen Financial Ratios
- The Gross Profit Margin over the past 38 years for AMGN is 75.16%.
- The Selling, General & Administrative Expenses for AMGN have been equal to 20.66% of Gross Profit Margin.
- The Research & Development expenses have been 18.55% of Revenue.
- The Interest Expense is 20.31% of Operating Income.
- The Net Earning history of AMGN is 22.68% of Total Revenues.
- Per Share Earnings over the last 38 years have been positive in 24 years.
Amgen Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Drug Manufacturers - General |
Sector: | Healthcare |
Current Symbol: | AMGN |
CUSIP: | 031162 |
Website: | amgen.com |
Debt
Debt-to-Equity Ratio: | 40.23 |
---|---|
Current Ratio: | 1.44 |
Quick Ratio: | 0.9 |
Price-to-Earnings
Trailing P/E Ratio: | 23.87 |
---|---|
Forward P/E Ratio: | 12.87 |